|
Post EUA study of Itolizumab in COVID-19 |
21/03/2022 |
CIM |
|
Curmeric- Safety-Community-Quarantine-COVID-19 |
22/01/2021 |
CEADEN |
|
Curmeric- Safety-Efficacy- Community-Quarantine-COVID-19 |
22/01/2021 |
CEADEN |
|
Curmeric- Nasal-Safety-Efficacy- Community-Quarantine -COVID-19 |
22/01/2021 |
CEADEN |
|
NAcGM3/VSSP-aids-patients drug resistant to antiretroviral treatment-Phase I-II |
22/04/2016 |
CIM |
|
DENIS Study |
22/10/2018 |
CIGB |
|
hR3 in metastatic or recurrent colorectal cancer |
22/11/2013 |
CIM |
|
Curmeric-Prevention-COVID-19-Health Workers-University Hospital General Calixto Garcia |
24/11/2020 |
CEADEN |
|
Seawater-Rhinitis-Children-Phase III |
25/09/2015 |
UDEA |
|
ior ®EPOCIM as a cardioprotective agent in the surgery of rheumatic valvular disease. |
26/08/2013 |
CIMAB |
|
Pharmacovigilance-VALERGEN-Asthma |
27/01/2017 |
BIOCEN |
|
Jusvinza in adult patients with Rheumatoid Arthritis from Camaguey and Eastern Provinces |
27/02/2024 |
CIGB_IB |
|
Hepatotoxicity by drugs |
27/04/2017 |
CenQfal |
|
D-002 and glucosamine/chondroitin sulphate in osteoarthritis |
27/06/2014 |
CPN |
|
Prevalence of positive evolutive PCR in patients with COVID 19 treated with rectal ozone therapy: observational study prospective cohort. |
27/10/2020 |
CPN |
|
SOBERANA 02 |
27/10/2020 |
FINLAY |
|
Homeostec for the treatment of chronic Chikungunya |
27/12/2016 |
SSA |
|
Exploratory study of BMT EV to stimulate immune response in patients with CKD-5 on iterated hemodialysis |
28/05/2020 |
BIOCEN |
|
Biomodulina T - IM - covid-19 - older adult |
29/05/2020 |
BIOCEN |
|
Retrospective observational study of the administration of Jusvinza, for the management of COVID-19 at the Hospital “Dr. Luis Diaz Soto”. |
29/10/2021 |
CIGB |
